A Phase III Randomized Study of Exemestane Versus Exemestane Placebo in Postmenopausal Women at Increased Risk for Breast Cancer

Grant

Date/time Interval

  • June 7, 2009 - November 11, 2013
  • Awarded By

    Total Award Amount

  • 406000.00
  • Direct Costs

  • 406000.00
  • Sponsor Award Id

  • Contributor

  • Krontiras M.D., Helen   Principal Investigator